Competitive intelligence professionals from Pfizer, Roche and Bayer are among the major pharmaceutical industry players who will give insight on the business of giving insight at the 2015 Pharma CI Conference and Exhibition in Parsippany, N.J. on Sept. 10-11. In addition to presenting on the value of actionable CI, ShiftCentral will be live-tweeting highlights from the event.
Presentations include:
- In the keynote address, Bayer VP of Business Insights Peter Barschdorff will outline the particulars of establishing in-house CI functionality at pharma firms;
- Roche CI expert Sabih Beck and Dr. Baljit Singh of Inovis offer a case study aimed at demonstrating the value of CI in shielding pharma firms from risk;
- Michael Rowe, Allergan’s executive director of Corporate Strategic Intelligence, will use real-life stories to show the importance of determining whether a non-competitor is about to become a competitor; and
- Roche/Genentech’s head of Global CI Salvatore Carlucci outlines three steps to drive effective strategy and decision-making through competitive simulations.
The event also includes panel and roundtable discussions on a wide variety of topics, including the use of CI in clinical trial design, using CI to support R&D and commercial operations, and more.
This article was originally published on ShiftCentral, now part of LAC Group.
Mario Thériault
Mario Thériault is Chief Business Development Officer and oversees all aspects of LAC Group’s growth strategy, partnership and alliance programs. Prior to LAC’s acquisition of ShiftCentral, Mario served as CEO and continuously evolved the company to emphasize the importance of strategic, curated intelligence to solve clients validated business needs.
Latest posts by Mario Thériault (see all)
- Build v. Buy - October 21, 2019
- ShiftCentral’s Mario Thériault on the evolution of CI and MI - July 11, 2019
- The history of information overload and your law firm’s market intelligence - September 20, 2018
Questions? Send me a message on our contact us form.
